Page last updated: 2024-11-07

spironolactone and Ovarian Diseases

spironolactone has been researched along with Ovarian Diseases in 2 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Ovarian Diseases: Pathological processes of the OVARY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gayral, MN1
Millet, D1
Netter, A1
Adashi, EY1

Reviews

1 review available for spironolactone and Ovarian Diseases

ArticleYear
Potential utility of gonadotropin-releasing hormone agonists in the management of ovarian hyperandrogenism.
    Fertility and sterility, 1990, Volume: 53, Issue:5

    Topics: Androgen Antagonists; Androgens; Biomechanical Phenomena; Contraceptives, Oral; Drug Therapy, Combin

1990

Other Studies

1 other study available for spironolactone and Ovarian Diseases

ArticleYear
[Ovarian hyperstimulation syndrome. Notes on the physiopathology and treatment apropos of 3 cases].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1975, Volume: 4, Issue:2

    Topics: Adult; Ascites; Capillary Permeability; Chorionic Gonadotropin; Female; Gonadotropins, Pituitary; Hu

1975